GSK (GSK) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free GSK Stock Alerts GBX 1,653 +12.50 (+0.76%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGSK (LON:GSK) Share Price Passes Above Two Hundred Day Moving Average of $1,549.75americanbankingnews.com - April 25 at 3:36 AMSCI, GSK launches $1m initiative to boost immunisation rate in Nigeria, Ethiopiamsn.com - April 24 at 10:46 AMUS regulator accepts GSK’s application to expand treatment of cancer drugmsn.com - April 24 at 10:46 AMGSK readies for pivotal ruling in Zantac casesft.com - April 24 at 10:46 AMGSK Trades At Low Price Multiples, But Its Pipeline Needs To Improveseekingalpha.com - April 19 at 10:15 AMGSK Canada expands charitable partnerships to include support of environmental sustainability and STEMfinance.yahoo.com - April 18 at 1:48 PMGSK (LON:GSK) Given Buy Rating at Deutsche Bank Aktiengesellschaftamericanbankingnews.com - April 18 at 5:30 AMDeutsche Bank Aktiengesellschaft Reaffirms "Buy" Rating for GSK (LON:GSK)marketbeat.com - April 17 at 11:56 AMGSK May 2024 28.000 call (GSK240517C00028000)finance.yahoo.com - April 16 at 7:19 PMLyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalystsseekingalpha.com - April 16 at 7:19 PMBrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwnfinance.yahoo.com - April 16 at 7:19 PMGSK's latest meningitis vaccine accepted for review by US regulatorlse.co.uk - April 16 at 9:18 AMFDA Accepts GSK's 5-in-1 Meningococcal ABCWY Vaccine Candidate For Regulatory Reviewmarkets.businessinsider.com - April 16 at 9:18 AMGSK plc (LON:GSK) Given Average Rating of "Hold" by Analystsmarketbeat.com - April 14 at 2:42 AMGSK plc: GSK's Strong Vaccine and HIV Portfolios Support Steady Growthfinance.yahoo.com - April 12 at 2:20 PMWall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yieldsmsn.com - April 11 at 7:34 PMDemocrats push more drug makers to lower the price of inhalersmsn.com - April 11 at 7:34 PMWill Biopharma Companies Shun Vaccine R&D In A New Pandemic?forbes.com - April 11 at 9:34 AMGSK (LON:GSK) Earns "Equal Weight" Rating from Barclaysmarketbeat.com - April 8 at 1:38 PMAkebia Therapeutics Surges on FDA Approval for Anemia Treatment (GSK)marketbeat.com - April 3 at 3:04 PMBuy Rating Affirmed for SCYNEXIS on Ibrexafungerp Success and Strong GSK Partnershipmarkets.businessinsider.com - April 2 at 10:29 PMScynexis: Update Following Restructuring Of GSK Dealseekingalpha.com - April 2 at 12:24 PMAkebia's Vafseo Faces Grim Market Outlook (Rating Downgrade)seekingalpha.com - April 2 at 7:19 AMFormer GSK office building in Navy Yard set for sheriff's sale to satisfy $78M foreclosure judgmentbizjournals.com - March 28 at 8:50 PMInsider Buying: GSK plc (LON:GSK) Insider Buys 434 Shares of Stockinsidertrades.com - March 23 at 1:43 AMGSK plc (LON:GSK) Insider Buys £7,213.08 in Stockmarketbeat.com - March 22 at 2:11 PMSenator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Monthbenzinga.com - March 21 at 8:29 AMSosei Regains Full Ownership From GSK Of Clinic-Ready GPR35 Agonist For Inflammatory Bowel Diseasemarkets.businessinsider.com - March 20 at 10:24 PMGSK to cap out-of-pocket inhaler costs in USreuters.com - March 20 at 5:21 PMGSK plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analystsmarketbeat.com - March 20 at 4:20 AMGSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancermsn.com - March 18 at 2:07 PMGSK says Jemperli combination gets good results for endometrial cancerlse.co.uk - March 18 at 9:05 AMGSK's Endometrial Cancer Treatment Study Shows Combination Potentialmarketwatch.com - March 18 at 9:05 AMGSK (LON:GSK) Rating Reiterated by Deutsche Bank Aktiengesellschaftmarketbeat.com - March 12 at 11:15 AMGSK Mar 2024 41.000 callfinance.yahoo.com - March 9 at 12:21 PMGSK Mar 2024 34.000 putfinance.yahoo.com - March 9 at 12:21 PMGSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Studymsn.com - March 7 at 1:34 PMShore Capital Reaffirms Buy Rating for GSK (LON:GSK)marketbeat.com - March 7 at 11:33 AMGSK’s Blenrep combo therapy meets key goal in multiple myeloma trialmsn.com - March 7 at 7:53 AMGSK's blood cancer drug meets main goal in late-stage trial; analysts tout comebackmsn.com - March 7 at 7:53 AMCORRECTED-GSK's new HIV drug formula could support longer dosing intervals (March 4)es-us.finanzas.yahoo.com - March 6 at 9:52 PMWHO warns of growing resistance to GSK's HIV drugmsn.com - March 6 at 4:52 PMNew HIV drug Cabotegravir that can be taken as little as three times a year boosts GSKmsn.com - March 4 at 5:30 PMGuggenheim lifts GSK to Buy on improved growth outlookinvesting.com - March 4 at 12:30 PMHow DEI is helping GSK get ahead of diseasetheglobeandmail.com - March 4 at 1:39 AMGSK boss’s annual pay package jumps 50% to £12.7mtheguardian.com - March 1 at 10:59 AMGSK's (GSK) Buy Rating Reaffirmed at Deutsche Bank Aktiengesellschaftmarketbeat.com - February 27 at 6:01 AMGSK drug meets goal in late-stage gonorrhea studyfinance.yahoo.com - February 26 at 1:52 PMGSK's Gepotidacin Oral Antibiotic Non-Inferior To Commonly Used Muscle-Injected Antibiotic Combo For Sexually Transmitted Infectionmsn.com - February 26 at 1:52 PMGSK’s new gonorrhoea pill ‘as good as injected antibiotic’thetimes.co.uk - February 26 at 8:52 AM Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Medicare Supplement Insurance? (Ad)Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.020.32▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼47▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AZN News Today HLN News Today DPH News Today SN News Today CTEC News Today HIK News Today HCM News Today INDV News Today EMIS News Today GNS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:GSK) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
